Recent News About Pfizer View More

Trump DOJ punishes hedge fund manager who sued drug companies and shorted their stocks

By Daniel Fisher | Feb 7, 2019

The Trump Justice Department, following a tougher policy toward dubious False Claims Act lawsuits by private citizens, has moved to dismiss a pair of lawsuits by a former hedge-fund manager who shorted stock in pharmaceutical companies he accused of a wide-ranging price-fixing conspiracy.

Wash. SC allows asbestos claim to proceed against Pfizer, adopts apparent manufacturer doctrine

By Charmaine Little | Nov 20, 2018

OLYMPIA, Wash. (Legal Newsline) – On Nov. 1, the Supreme Court of the State of Washington adopted the apparent manufacturer doctrine in a case concerning a man’s exposure to asbestos products that allegedly ultimately led to his sickness and passing.

Pfizer settles allegations its 'Pay No More Than' coupon program deceived consumers

By Marian Johns | Oct 17, 2018

NEW YORK — Pfizer Inc. has agreed to pay more than $2.5 million in penalties to settle charges by the New York State Attorney General's Office of deceptively marketing its co-payment coupon program "Pay No More Than."

The Record Network